D-0046-2021 Class III Terminated

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0046-2021 was initiated by ANI Pharmaceuticals, Inc. on Oct 9, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months. The recall status is terminated (terminated Jan 19, 2022). Affected quantity: 24972 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 28, 2020
Initiation Date
Oct 9, 2020
Termination Date
Jan 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24972 bottles

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 20 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-280-10

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot: 19T15 Exp. Dec. 2021, 20D02, 20D03 Exp. Mar. 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0046-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0046-2021. Report a data issue: hello@regdatalab.com.